A paper by Norihumi Iijima (National Institute of Biomedical Innovation, Health and Nutrition) and Ken Ishii’s group (Division of Adjuvant Innovation) was published in Journal of Autoimmunity.

miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases

Iijima N, Yamaguchi M, Hayashi T, Rui Y, Ohira Y, Miyamoto Y, Niino M, Okuno T, Suzuki O, Oka M, Ishii KJ